Elie B Lowenstein1, Joshua A Zeichner. Show Affiliations » 1. Department of Dermatology, Mount Sinai Medical Center, New York, New York 10029, USA.
Abstract
Entities: Chemical Disease
Mesh： See more » AdalimumabAnti-Inflammatory Agents/administration & dosageAnti-Inflammatory Agents/therapeutic useAntibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/therapeutic useBalanitis Xerotica Obliterans/drug therapyBalanitis Xerotica Obliterans/pathologyHumansInjections, IntralesionalMaleMiddle AgedTreatment Outcome
Substances： See more » Anti-Inflammatory AgentsAntibodies, Monoclonal, HumanizedAdalimumab
Year: 2013 PMID： 23324752 DOI： 10.1001/2013.jamadermatol.39
Source DB: PubMed Journal: JAMA Dermatol ISSN： 2168-6068 Impact factor: 10.282